Candidate drug that boosts protective brain protein in mice has potential to treat Alzheimer's disease

Candidate drug that boosts protective brain protein in mice has potential to treat Alzheimer's disease

As researchers work to improve treatment of Alzheimer's disease, new research by UCLA Health identified a candidate drug that reduces levels of a toxic form of a protein in the brain caused by the disease and improved memory in mice by boosting production of a protective protein.

Drug Candidate Boosts Clusterin Production to Reduce Amyloid-Beta Plaques and Improve Memory in Mice

Researchers have identified a potential drug that may a […] The post Drug Candidate Boosts Clusterin Production to Reduce Amyloid-Beta Plaques and Improve Memory in Mice first appeared on GeneOnline News. The post Drug Candidate Boosts Clusterin Production to Reduce Amyloid-Beta Plaques and Improve Memory in Mice appeared first on GeneOnline News.

Alzheimer Europe | World Health Assembly approves six-year extension to the Global Action Plan on the Public Health Response to Dementia

On 23 May 2025, during the 78th World Health Assembly in Geneva (Switzerland), a six-year extension to the Global Action Plan on the Public Health Response to Dementia was adopt

Researchers discover molecule that reverses cognitive deficits associated with dementia and aging

Dementia affects millions globally, impacting memory, reasoning, and everyday activities. As the population ages, understanding and addressing cognitive decline becomes increasingly critical. Alzheimer’s disease, the most common form of dementia, affects around 50 million people worldwide. This number is projected to triple to over 150 million by 2050, especially burdening low-income and middle-income countries. Globally, dementia care costs nea…